Avalon Pharmaceuticals
Avalon, ChemDiv alliance to focus on oncology drug discovery and development
Published in Food and Drug Law Weekly, August 25th, 2006
Avalon will use its proprietary AvalonRx platform to discover new active compounds in screens against selected targets and target pathways. ChemDiv will provide Avalon access to its Discovery outSource services platform, including the world's largest commercially available chemical library, as well as medicinal and synthetic chemistry for the discovery and development of new active compounds. Avalon and ChemDiv will share in the costs of development and the value of any lead candidate resulting from their...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
More Articles from Food and Drug Law Weekly
- Abbott
Abbott gets U.S. FDA clearance for test to diagnose congestive heart failure - Aida Pharmaceuticals
Aida Pharmaceuticals completes phase I trials for gene-therapy drug - Bovie Medical
Bovie Medical reports U.S. FDA clears suture removal device for marketing - Chembio Diagnostics
Chembio applies for CLIA Waiver for SURE CHECK HIV 1/2, go-ahead would expand domestic marketing - EMD Chemicals
EMD Chemicals gets U.S. FDA approval for Candurin for use in drugs - Elan
Biogen Idec, Elan announce availability of Tysabri to treat relapsing forms of multiple sclerosis - More from this issue of Food and Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
